Testing effectiveness (Phase 2)WithdrawnNCT00415649
What this trial is testing
Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)